M-001 vaccine is a recombinant protein containing 9 conserved epitopes from Influenza A and B that are common to the vast majority of influenza viruses.Read more...
M-M-R II Vaccine
M-M-R II vaccine is also known as Measles, Mumps, and Rubella Virus Vaccine Live, is a live virus MMR vaccine.Read more...
M72/AS01E Tuberculosis Vaccine
M72/AS01E is a subunit vaccine candidate comprised of an immunogenic fusion protein (M72) derived from two Mycobacterium tuberculosis (M.tb) antigens (MTB32A and MTB39A), and the adjuvant AS01E.Read more...
Measles Vaccines March 2023
Measles can be prevented by vaccination.Read more...
Medigen COVID-19 Vaccine
Medigen MVC-COV1901 COVID-19 Vaccine is adjuvanted with Dynavax CpG 1018.Read more...
Menactra contains N meningitidis serogroup 8 A, C, Y and W-135 capsular polysaccharide antigens individually conjugated to diphtheria toxoid 9 protein.Read more...
Meningococcal Vaccines March 2023
Meningococcal vaccines prevent illnesses caused by bacteria called Neisseria meningitidis.Read more...
Menveo Meningococcal Vaccine
MENVEO is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135.Read more...
MK-7110 COVID-19 Therapeutic
MK-7110 (CD24Fc) COVID-19 Therapeutic candidate is a first-in-class recombinant fusion protein that targets the innate immune system.Read more...
Mosquirix RTSS/AS01 Malaria Vaccine
Mosquirix (RTS,S/AS01) (RTS,S) is a recombinant malaria vaccine.Read more...
mRNA Influenza Vaccine
Pfizer's mRNA Influenza Vaccine has entered a Phase 3 clinical trialRead more...
mRNA-1010 Quadrivalent Influenza Vaccine
Moderna mRNA-1010 Quadrivalent Influenza Vaccine candidate.Read more...
mRNA-1189 Epstein-Barr Virus Vaccine
mRNA-1189 Epstein-Barr Virus vaccine candidate is being developed to prevent EBV-induced IM and potentially EBV infectionRead more...
mRNA-1345 RSV Vaccine
Moderna mRNA-1345 Respiratory Syncytial Virus (RSV) Vaccine candidate.Read more...
mRNA-1574 HIV Vaccine
Moderna mRNA-1574 is an HIV Vaccine candidate that utilizes multiple mRNAs encoded native-like HIV trimers.Read more...
mRNA-1608 Herpes Vaccine
Moderna mRNA-1608 herpes mRNA vaccine candidate is targeted against HSV-2.Read more...
mRNA-1647 Cytomegalovirus Vaccine
Moderna Inc. mRNA-1647 vaccine is designed to produce an immune response to both pentamer and gB antigens to prevent CMV infection.Read more...
mRNA-1653 hMPV+PIV3 Vaccine
mRNA-1653 is a combination vaccine that consists of two distinct mRNA sequences encoding the fusion (F) proteins of hMPV and PIV3 formulated in Moderna’s proprietary lipid nanoparticle (LNP) technology.Read more...
mRNA-1893 Zika Vaccine
Moderna mRNA-1893 vaccine contains an mRNA sequence encoding for the structural proteins of the Zika virus and is designed to cause cells to secrete virus-like particles.Read more...
Moderna's mRNA-4157/V940 is a therapeutic cancer vaccine candidate.Read more...
MRT5400/MRT5401 mRNA Influenza Vaccine
Sanofi's MRT5400 and MRT5401 are mRNA Influenza Vaccine candidates that are entering a phase 1 clinical trial.Read more...
MRT5500 mRNA Vaccine
Translate Bio and Sanofi MRT5500 is an mRNA SARS-CoV-2 vaccine candidateRead more...
MTBVAC Tuberculosis Vaccine
MTBVAC Tuberculosis Vaccine is a live attenuated vaccine candidate against Mycobacterium tuberculosis.Read more...
MV-CHIK Chikungunya Vaccine
MV-CHIK is a vaccine candidate utilizing Themis’ measles vector platform. MV-CHIK consists of a recombinant live Schwarz-strain measles-vectored vaccine expressing chikungunya virus structural proteins.Read more...
MV-LASV Lassa Fever Vaccine
MV-LASV vaccine candidate is a recombinant, live-attenuated, viral vectored vaccine, based on the backbone of the measles Schwarz virus strain for prophylaxis of Lassa infectionRead more...
MVA MERS-S Vaccine
MVA-MERS-S (Modified Vaccinia virus Ankara) is a vaccine candidate that contains the full-length spike gene of MERS-CoV.Read more...
MVA-BN RSV Vaccine
MVA-BN RSV vaccine incorporates five different RSV antigens to stimulate a broad immune responseRead more...
MVA-BN WEV Equine Encephalitis Vaccine
MVA-BN WEV is a prophylactic vaccine candidate against three equine encephalitis viruses.Read more...
MVA-M1+NP Influenza A Vaccine
MVA-M1+NP vaccine candidate consists of MVA, a replication-deficient pox viral vector that has been safely tested in thousands of patients, to generate a strong immune reaction against Matrix 1 (M1) and Nucleoprotein (NP) influenza antigens. Read more...
MVX-ONCO-1 Cancer Immunotherapy Vaccine
MVX-ONCO-1 is an anti-cancer therapy based upon triggering the patient's own natural immune responseRead more...
